Sunday, November 8, 2026

South Sudan Oil Contamination: "Among Highest in the World," Study Finds

Terry Swartzberg

July 7, 2018

South Sudan oil workers attempting to contain the spill. Photo by: Nile Institute of Environmental Health.
MUNICH, Germany (ViaNews) - Professor Fritz Pragst of Berlin's Institute for Forensic Medicine is one of the leading forensic toxicologists in the world. Read: Briefing on Big Oil’s Contamination of South Sudan Professor Pragst headed a team of scientists that produced in 2017 the definitive study on the levels of lead, barium and other health-endangering substances in the hairs of people living in the vicinity of South Sudan's oil fields. Here is his statement on the study's findings. "The levels of lead concentrations found in the hairs of residents in South Sudan were, in some cases, among the highest in the world. While further tests - of resident blood- would be required to ascertain actual damaging of health - the direct and immediate endangerment of lead poisoning for human beings and animals is extremely well and unequivocally documented." Read: German NGO struggle for clean water in South Sudan South Sudan residents report a large number of deformed children, birth complications, and sexual dysfunctions. Read: Leading Rights Groups Reveal How a South Sudan Oil Company Plays a Key Role in Prolonging Conflict

Categories

Tags

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com